Cathie Wood’s ARK sells Rocket Lab, buys Intellia stock

ARK Invest sold Rocket Lab shares and bought Intellia Therapeutics shares in its latest daily trade disclosure for Monday, April 27.

According to market reports, ARKQ sold 50,312 Rocket Lab shares, while ARKK and ARKG bought a combined 263,848 Intellia Therapeutics shares. The trades were reported on April 27 and April 28 by Investing.com and echoed by other outlets.

ARK’s trade notifications page says its daily files reflect end-of-day portfolio adjustments in its actively managed ETFs. The latest moves fit that pattern of regular rebalancing rather than a company-specific catalyst.

For investors, the main takeaway is the direction of ARK’s active rotation: out of Rocket Lab and into Intellia. The disclosure does not explain the firm’s specific rationale for the trades.

Because these are routine daily trade filings, the next update would likely be the following disclosure rather than a new corporate announcement.